CD200 and cancer: As EMT, invasive ability, and cancer stemness are usually associated with dedifferentiation and are well-known phenotypes contributing to a poor therapeutic response to contemporary treatments, we attempted to determine the role of CD200 in the evolutional induction of chemoresistance in human and mouse HNSCC models.